DEFERIPRONE MARKET ANALYSIS
Deferiprone Market – Competitive Landscape
The two major players operating in the deferiprone market are Apotex and Cipla Limited. Key market player are engaged in adopting various growth strategies such as mergers, collaborations, acquisition, and introduction of new products in order to strengthen their position in the global market. For instance, in 2016, Cipla limited completed its US$ 550-million acquisition of generic drug key manufactures, Exelan Pharma and InvaGen. This acquisition is expected to boost Cipla Limited’s U.S. business, by providing Cipla with 32 marketed products, 40 approved abbreviated new drug applications (ANDAs), and a pipeline of 30 products, which are expected to be approved in the near future.
Deferiprone Market – Taxonomy
On the basis of type, the global deferiprone market is segmented into:
Deferiprone Market Report Snapshots
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients